Berberine Bioavailability, Capsule Burden, and Routine Fit: What Brands Should Evaluate
A B2B formulation article on berberine bioavailability, active loading, daily serving design, GI tolerance, and routine-fit positioning.
Berberine Pro-Micelle Fiber 50: A Dry-Powder Platform for Routine-Friendly Berberine
A B2B technical guide to Berberine Pro-Micelle Fiber 50, dry-powder self-emulsifying design, 50% active loading, and 1 g/day routine fit.
What a 30-Day Healthy-Adult Pilot Can Support for Magnesium Acetyl Taurate
A guide to using Magnesium Acetyl Taurate 30-day tolerability and user-experience pilot endpoints for B2B formulation review without disease claims.
Magnesium Acetyl Taurate: A Calm-Focus Magnesium Ingredient With Its Own Position
A B2B evaluation guide for Magnesium Acetyl Taurate, acetyl-taurate identity, calm-focus positioning, and evidence package review.
Methyl-Burden-Aware NAD+ Support: Claim Language for Technical Buyers
A claim-boundary guide for positioning Vital Porphyrin and methyl-burden-aware NAD+ support without overclaiming safety or disease benefits.
Endogenous NAD+ Renewal Positioning: Where Vital Porphyrin Fits
A B2B technical note on Vital Porphyrin, endogenous NAD+ renewal positioning, low-dose formulation space, and methyl-burden-aware language.
NAD Pro Formulation Fit: Building a Longevity Product With a Reviewable Data Story
A formulation guide for using NAD Pro in premium longevity products with dose logic, delivery-system language, evidence review, and claim discipline.
How to Evaluate an NAD+ Ingredient Platform Beyond the Ingredient Name
A B2B guide to evaluating NAD+ ingredient platforms through human biomarker response, analytical method support, formulation fit, and claim boundaries.